Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
Reviews delivering appropriate evidence-based nursing care specific to patients with either right ventricular or left ventricular infarctions.
Goals and Outcomes
Goals and Learning Outcomes
Despite an increase in the application of evidence-based treatment modalities and awareness and treatment of cardiovascular risk factors, cardiac arrest remains the leading cause of death in the U.S. (Virani et al., 2020). About 356,000 people in the U.S. experience a cardiac arrest outside a hospital that is assessed by EMS personnel. About 34% of those who experience a coronary event in each year will die from it (Virani et al., 2020). Fifteen percent of people experiencing a myocardial infarction (MI) will die, most within the first hour after the symptoms begin (from ventricular fibrillation) and before the patient arrives at the ED (Virani et al., 2020). Right ventricular (RV) infarction is more challenging to diagnose than left ventricular (LV) infarction and is associated with higher in-hospital mortality (Thygesen et al., 2018).

The goal of this course is to provide nurses in acute care with knowledge of right and left ventricular infarctions.


After taking this course, you should be able to:

  • Differentiate the physiological changes specific to RV versus LV MIs
  • List three complications associated with MIs
  • Discuss therapeutic modalities useful in the management of MIs
  • Differentiate the physiological etiology and treatments specific to right versus left myocardial infarctions.
  • List the symptoms and complications associated with myocardial infarctions.
  • Discuss therapeutic modalities useful in the management of myocardial infarctions.
  • Identify the complications associated with recovery period after a myocardial infarction and techniques for monitoring them.

Course Termination Date: 08/05/23

Content Expiration Date: 06/30/23

Course Originally Released On: 05/01/19
Details
Course Details

Course Originally Released on : 5/1/2019

REL-ACU-0-60173

Course Author

Elizabeth Kellerman

MSN, RN

Kathryn M. Perlman

MSN, RN

Joanne McGlinchey

MSN, RN-BC, PCCN

Kiersten Henry

MS, ACNP-BC, CCNS, CCRN-CMC

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.